Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Square Has Plenty of Growth, but SQ Stock Is Fully Valued

By Mark R. Hake, CFA

Square has plenty of growth in its future. But unless EBITDA doubles in three years, SQ stock will not stay at its price today.

TAP Stock Is a Great Buy for Free Cash Flow and Dividend Growth Alone

By Mark R. Hake, CFA

TAP stock benefits from Molson Coor's FCF and dividend growth. Molson has paid down the Miller acquisition debt every year and hiked the TAP stock dividend.

Amarin Stock is Still Fully Valued Despite All the Good News

By Mark R. Hake, CFA

AMRN stock is likely fairly priced -- possibly even overpriced -- right now. It might take more time before analysts and the company actually raise their revenue and cash flow estimates based on patient uptake of Vascepa.

With Oil At a Low, BP Offers Great Value

By Mark R. Hake, CFA

With oil prices at a low, BP stock makes a great investment, especially as it looks to return 12% annually to investors through 2024.

Aphria Stock is Likely Stuck Biding Time til the Pot Grower Gets Profitable

By Mark R. Hake, CFA

Aphria stock is biding time until the company gets profitable. Unless profits appear soon, Aphria stock may be headed further down.

Load More